B-细胞淋巴瘤因子2(Bcl2)重组蛋白 Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2) B-Cell CLL/Lymphoma 2来源:原核表达宿主:E.coli内毒素水平:<1.0EU/µg(LAL法测定)亚细胞定位:外泌体预测分子量:26.7kDa实际分子量:26kDa(差异分析请参阅说明书)...
Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma Tim Richardson Hishan Tharmaseelan Udo Holtick CorrespondenceOpen Access15 Nov 2024Bone Marrow Transplantation Volume: 60, P: 244-246 Limited stage high grade B-cell lymphoma withMYC, BCL2and/...
In vitro and mouse studies suggest a class of dual BCL2 and Bcl-xL inhibitors could help treat lung cancer. Further details on the research, next steps and licensing status are discussed in the article.Nature Publishing Group USScience-Business eXchange...
研究人员聚焦 DLBCL 线粒体代谢,发现 MPC2 在 DLBCL 中高表达,敲低 MPC2 可抑制肿瘤进展。该研究为 DLBCL 治疗提供新靶点,具有重要意义。 在医学领域,弥漫大 B 细胞淋巴瘤(Diffuse Large B-Cell Lymphoma,DLBCL)是一种常见且棘手的非霍奇金淋巴瘤。它如同隐藏在人体免疫系统中的 “捣乱分子”,严重威胁着人们...
B cell lymphoma 2 (BCL2; BCL-2)B cell lymphoma 2 (BCL2; BCL-2)Summary Cationic liposomes loaded with a proapoptotic peptide and an antisense compound could increase the efficacy of some melanoma therapies. In a mouse model of melanoma, liposomes carrying the proapoptotic peptide D-(KLAKLAK...
3.Witzig TE, Vukov AM, Habermann TM, et al. Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non-Hodgkin's lymphoma: a phase II trial in the North Central Cancer Treatment Gro...
In a series of 193 patients with advanced stage diffuse large-cell lymphoma (DLCL) treated with MACOP-B, 18 (11%) were defined as having a stage II large B-cell lymphoma with sclerosis of the mediastinum. This type of lymphoma has been reported to have a highly aggressive behaviour and ...
为探究髓源性抑制细胞(MDSCs)在弥漫大 B 细胞淋巴瘤(DLBCL)中的异常情况,福建医科大学附属协和医院研究人员开展相关研究。结果发现 DLBCL 患者 MDSCs 异常扩增且免疫抑制功能增强,这为 DLBCL 免疫治疗提供新思路。 在淋巴瘤的世界里,弥漫大 B 细胞淋巴瘤(Diffuse large B-cell lymphoma,DLBCL)是一种极具挑战性的...
2024年7月,王朝夫主任医师团队在《International journal of biological science 》【IF8.2,Q1】杂志发表题名为“KMT2Dmutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell...
B-cell CLL/lymphoma 2doi:10.1007/978-3-642-16483-5_547BCL2Springer Berlin Heidelberg